Central AsianResearch Index

In silico assessment of ESR1 gene expression in malignancies

The Estrogen Receptor 1 (ESR1) gene plays key roles in regulating ER-responsive genes and affects many physiological processes. This gene encodes the estrogen receptor (ERα), which is essential for cellular proliferation and differentiation and is implicated in various malignancies, including osteoporosis, colon, ovarian, endometrial, and breast cancer. Due to the association of the mutagenic form of ESR1 with many types of cancers, it is also being investigated as a potential biomarker for cancers. The bulk tissue expression of the ESR1 gene is found mainly in the tissues associated with female reproductive organs (breast, cervix tissue, fallopian tubes, uterus, and vagina). This study analyzed ESR1 expression in malignancies using in silico tools. TNMplot, TIMER2.0, GTEx, GEPIA, TCGA, etc., were used to investigate differential expression of ESR1 genes across various cancers, explore gene correlations, and assess prognostic impact and survival outcomes in patients. This study revealed that tumor tissue showed higher ESR1 expression than normal or metastatic tissues. ESR1 expression was high in all pathological stages throughout the course of the malignancy. Differential overall survival was observed among breast, cervical, uterine, and ovarian malignancies. Insights from this research could lead to the development of more effective targeted therapies, improving patient outcomes, and advancing cancer treatment strategies. This aspect of gene co-expression and linked transcription may be the subject of future molecular research.

Сведения

Опубликовано
2026 · № 1, С. 152-162
Язык
Английский
ISSN
2305-6045 · 2305-6053
Издатель
Karaganda Medical University
Аффилиации
Department of Biotechnology, Chandigarh College of Technology, Chandigarh Group of Colleges